Control of Massive Hematuria in Idiopathic Hemorrhagic Cystitis after Administration of Conjugated Estrogen
- 1 November 1992
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 148 (5 Part 1) , 1524-1525
- https://doi.org/10.1016/s0022-5347(17)36956-2
Abstract
A renal transplant patient with severe hemorrhagic cystitis of idiopathic etiology was treated initially with intravenous administration of conjugated estrogen (1 mg./kg.), followed on day 2 and thereafter with 5 mg. per day orally for 3 weeks. Hematuria decreased in intensity within 10 hours and disappeared within 48 hours. Hematuria did not recur by 6 months after completion of oral doses of conjugated estrogen. Complications or other side effects were not observed. In our experience conjugated estrogen controls hematuria in patients with idiopathic hemorrhagic cystitis and this form of treatment must be considered in this condition.Keywords
This publication has 5 references indexed in Scilit:
- Treatment of Radiation or Cyclophosphamide Induced Hemorrhagic Cystitis using Conjugated EstrogenJournal of Urology, 1990
- Prostaglandin E1 Bladder Instillations to Control Severe Hemorrhagic CystitisJournal of Urology, 1990
- Hemorrhagic Cystitis: A ReviewJournal of Urology, 1990
- Adenoviral Acute Hemorrhagic Cystitis following Renal TransplantationAmerican Journal of Nephrology, 1990
- TREATMENT OF URAEMIC BLEEDING WITH CONJUGATED OESTROGENThe Lancet, 1984